Association of lithium treatment with cardiac structure and circulating leukocyte distribution in patients with

Pao-Huan Chen1, Cheng-Yi Hsiao2, Shuo-Ju Chiang3

  • 1Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

PubMed

Insights

Lithium treatment in bipolar disorder (BD) patients is associated with reduced left ventricular (LV) concentricity and LV relative wall thickness (RWT). This suggests lithium may protect cardiac function by regulating leukocytes, potentially lowering heart failure risk.

Area of Science:

  • Cardiology
  • Psychiatry
  • Hematology

Background:

  • Lithium's anti-inflammatory properties may protect cardiac function in bipolar disorder (BD).
  • Complete blood count (CBC) reflects inflammation and cardiovascular disease risk.
  • This study examines lithium's impact on cardiac geometry and CBC in BD patients.

Purpose of the Study:

  • Investigate the association between lithium treatment and left ventricular (LV) geometric patterns.
  • Explore the relationship between lithium use, LV geometry, and complete blood count (CBC) indices in BD patients.

Main Methods:

  • 108 euthymic BD-I patients (58 on lithium) underwent echocardiography and CBC.
  • LV concentricity was categorized as remodeling or hypertrophy.
  • Echocardiographic analysis followed American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines.

Main Results:

  • 60% of patients had LV concentricity; lithium users had lower prevalence (48.3%) vs. non-users (72.0%).
  • Lithium users showed lower LV relative wall thickness (RWT), lymphocyte counts, and higher neutrophil-lymphocyte ratio.
  • Lithium exposure, neutrophil-lymphocyte ratio, and monocyte-lymphocyte ratio negatively correlated with LV RWT.

Conclusions:

  • Lithium may reduce heart failure risk in BD by decreasing LV concentricity and RWT via leukocyte regulation.
  • Findings suggest lithium's cardioprotective effects in BD patients.
  • Future research should include leukocyte dynamics markers to confirm these findings.
Abstract

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
533
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
606
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K